Back
Biosyent 10K Form
Buy
62
RX.V
Biosyent
Last Price:
11.9800
Seasonality Move:
24.84%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RX.V News And Ratings
See the #1 stock for the next 7 days that we like better than RX.V
RX.V Financial Statistics
Sales & Book Value
| Annual Sales: | $31.59M |
|---|---|
| Cash Flow: | $2M |
| Price / Cash Flow: | 70.99 |
| Annual Sales: | $3.22 |
| Price / Book: | 3.6 |
Profitability
| EPS (TTM): | 0.59900 |
|---|---|
| Net Income (TTM): | $7.11M |
| Gross Margin: | $25.6M |
| Return on Equity: | 20.12% |
| Return on Assets: | 16.93% |
Biosyent Earnings Forecast
Key Biosyent Financial Ratios
- The Gross Profit Margin over the past 27 years for RX.V is 81.03%.
- The Selling, General & Administrative Expenses for RX.V have been equal to 0.00% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 1.06% of Operating Income.
- The Net Earning history of RX.V is 20.45% of Total Revenues.
- Per Share Earnings over the last 27 years have been positive in 16 years.
Biosyent Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | TSXV |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | RX.V |
| Website: | biosyent.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.92 |
| Quick Ratio: | 3.05 |
Price-to-Earnings
| Trailing P/E Ratio: | 21.86 |
|---|---|
| Forward P/E Ratio: | 0 |